Erratum: Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling (Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling (2012) 150(4) (780–791), (S0092867412008756), (10.1016/j.cell.2012.06.037));Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling

Cell

Volumn 150, Issue 4, 2012, Pages 780-791

  Yu, Fa Xing ^a   Zhao, Bin ^c   Panupinthu, Nattapon ^d   Jewell, Jenna L ^a   Lian, Ian ^a   Wang, Lloyd H ^a   Zhao, Jiagang ^a   Yuan, Haixin ^a   Tumaneng, Karen ^a   Li, Hairi ^b   Fu, Xiang Dong ^b   Mills, Gordon B ^d   Guan, Kun Liang ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ZHEJIANG UNIVERSITY   (China)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; G PROTEIN COUPLED RECEPTOR; GLUCAGON; LATS 1 KINASE; LATS 2 KINASE; LYSOPHOSPHATIDIC ACID; ONCOPROTEIN; PHOSPHOTRANSFERASE; SPHINGOSINE 1 PHOSPHATE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; YES ASSOCIATED PROTEIN;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; DEPHOSPHORYLATION; ENZYME ACTIVITY; GENE; GENE EXPRESSION; HIPPO GENE; HUMAN; HUMAN CELL; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL;

MAMMALIA;

EID: 84865260845     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2024.02.007     Document Type: Erratum

References (47)

1. S. Benhamouche, M. Curto, I. Saotome, A.B. Gladden, C.H. Liu, M. Giovannini, and A.I. McClatchey Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver Genes Dev. 24 2010 1718 1730
2. J. Cai, N. Zhang, Y. Zheng, R.F. de Wilde, A. Maitra, and D. Pan The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program Genes Dev. 24 2010 2383 2388
3. F.D. Camargo, S. Gokhale, J.B. Johnnidis, D. Fu, G.W. Bell, R. Jaenisch, and T.R. Brummelkamp YAP1 increases organ size and expands undifferentiated progenitor cells Curr. Biol. 17 2007 2054 2060 (Pubitemid 350180465)
4. X. Cao, S.L. Pfaff, and F.H. Gage YAP regulates neural progenitor cell number via the TEA domain transcription factor Genes Dev. 22 2008 3320 3334
5. S.W. Chan, C.J. Lim, K. Guo, C.P. Ng, I. Lee, W. Hunziker, Q. Zeng, and W. Hong A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells Cancer Res. 68 2008 2592 2598 (Pubitemid 351556257)
6. J.W. Choi, D.R. Herr, K. Noguchi, Y.C. Yung, C.W. Lee, T. Mutoh, M.E. Lin, S.T. Teo, K.E. Park, A.N. Mosley, and J. Chun LPA receptors: subtypes and biological actions Annu. Rev. Pharmacol. Toxicol. 50 2010 157 186
7. J. Dong, G. Feldmann, J. Huang, S. Wu, N. Zhang, S.A. Comerford, M.F. Gayyed, R.A. Anders, A. Maitra, and D. Pan Elucidation of a universal size-control mechanism in Drosophila and mammals Cell 130 2007 1120 1133 (Pubitemid 47410268)
8. R.T. Dorsam, and J.S. Gutkind G-protein-coupled receptors and cancer Nat. Rev. Cancer 7 2007 79 94 (Pubitemid 46164746)
9. S. Dupont, L. Morsut, M. Aragona, E. Enzo, S. Giulitti, M. Cordenonsi, F. Zanconato, J. Le Digabel, M. Forcato, and S. Bicciato Role of YAP/TAZ in mechanotransduction Nature 474 2011 179 183
10. B.G. Fernández, P. Gaspar, C. Brás-Pereira, B. Jezowska, S.R. Rebelo, and F. Janody Actin-Capping Protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila Development 138 2011 2337 2346
11. Y. Hao, A. Chun, K. Cheung, B. Rashidi, and X. Yang Tumor suppressor LATS1 is a negative regulator of oncogene YAP J. Biol. Chem. 283 2008 5496 5509
12. Z. Kan, B.S. Jaiswal, J. Stinson, V. Janakiraman, D. Bhatt, H.M. Stern, P. Yue, P.M. Haverty, R. Bourgon, and J. Zheng Diverse somatic mutation patterns and pathway alterations in human cancers Nature 466 2010 869 873
13. D. Kuang, Y. Yao, J. Lam, R.G. Tsushima, and D.R. Hampson Cloning and characterization of a family C orphan G-protein coupled receptor J. Neurochem. 93 2005 383 391 (Pubitemid 40547495)
14. C.H. Lee, K. Inoki, and K.L. Guan mTOR pathway as a target in tissue hypertrophy Annu. Rev. Pharmacol. Toxicol. 47 2007 443 467
15. K.P. Lee, J.H. Lee, T.S. Kim, T.H. Kim, H.D. Park, J.S. Byun, M.C. Kim, W.I. Jeong, D.F. Calvisi, J.M. Kim, and D.S. Lim The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis Proc. Natl. Acad. Sci. USA 107 2010 8248 8253
16. Q.Y. Lei, H. Zhang, B. Zhao, Z.Y. Zha, F. Bai, X.H. Pei, S. Zhao, Y. Xiong, and K.L. Guan TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway Mol. Cell. Biol. 28 2008 2426 2436 (Pubitemid 351429986)
17. L. Li, S.H. Yun, J. Keblesh, B.L. Trommer, H. Xiong, J. Radulovic, and W.G. Tourtellotte Egr3, a synaptic activity regulated transcription factor that is essential for learning and memory Mol. Cell. Neurosci. 35 2007 76 88 (Pubitemid 46636302)
18. S. Liu, M. Umezu-Goto, M. Murph, Y. Lu, W. Liu, F. Zhang, S. Yu, L.C. Stephens, X. Cui, and G. Murrow Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases Cancer Cell 15 2009 539 550
19. C.Y. Liu, Z.Y. Zha, X. Zhou, H. Zhang, W. Huang, D. Zhao, T. Li, S.W. Chan, C.J. Lim, and W. Hong The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCFbeta-TrCP E3 ligase J. Biol. Chem. 285 2010 37159 37169
20. L. Lu, Y. Li, S.M. Kim, W. Bossuyt, P. Liu, Q. Qiu, Y. Wang, G. Halder, M.J. Finegold, J.S. Lee, and R.L. Johnson Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver Proc. Natl. Acad. Sci. USA 107 2010 1437 1442
21. A. Ludwig, P. Uvarov, S. Soni, J. Thomas-Crusells, M.S. Airaksinen, and C. Rivera Early growth response 4 mediates BDNF induction of potassium chloride cotransporter 2 transcription J. Neurosci. 31 2011 644 649
22. H. Ohta, K. Sato, N. Murata, A. Damirin, E. Malchinkhuu, J. Kon, T. Kimura, M. Tobo, Y. Yamazaki, and T. Watanabe Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors Mol. Pharmacol. 64 2003 994 1005 (Pubitemid 37153068)
23. F. Oury, G. Sumara, O. Sumara, M. Ferron, H. Chang, C.E. Smith, L. Hermo, S. Suarez, B.L. Roth, P. Ducy, and G. Karsenty Endocrine regulation of male fertility by the skeleton Cell 144 2011 796 809
24. M. Overholtzer, J. Zhang, G.A. Smolen, B. Muir, W. Li, D.C. Sgroi, C.X. Deng, J.S. Brugge, and D.A. Haber Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon Proc. Natl. Acad. Sci. USA 103 2006 12405 12410 (Pubitemid 44267272)
25. D. Pan Hippo signaling in organ size control Genes Dev. 21 2007 886 897 (Pubitemid 46625638)
26. T.D. Prickett, X. Wei, I. Cardenas-Navia, J.K. Teer, J.C. Lin, V. Walia, J. Gartner, J. Jiang, P.F. Cherukuri, and A. Molinolo Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma Nat. Genet. 43 2011 1119 1126
27. O. Quehenberger, A.M. Armando, A.H. Brown, S.B. Milne, D.S. Myers, A.H. Merrill, S. Bandyopadhyay, K.N. Jones, S. Kelly, and R.L. Shaner Lipidomics reveals a remarkable diversity of lipids in human plasma J. Lipid Res. 51 2010 3299 3305
28. C. Rauskolb, G. Pan, B.V. Reddy, H. Oh, and K.D. Irvine Zyxin links fat signaling to the hippo pathway PLoS Biol. 9 2011 e1000624
29. H. Rosen, P.J. Gonzalez-Cabrera, M.G. Sanna, and S. Brown Sphingosine 1-phosphate receptor signaling Annu. Rev. Biochem. 78 2009 743 768
30. L. Sansores-Garcia, W. Bossuyt, K. Wada, S. Yonemura, C. Tao, H. Sasaki, and G. Halder Modulating F-actin organization induces organ growth by affecting the Hippo pathway EMBO J. 30 2011 2325 2335
31. D. Shida, J. Kitayama, H. Yamaguchi, Y. Okaji, N.H. Tsuno, T. Watanabe, Y. Takuwa, and H. Nagawa Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1 Cancer Res. 63 2003 1706 1711 (Pubitemid 36373664)
32. A.A. Steinhardt, M.F. Gayyed, A.P. Klein, J. Dong, A. Maitra, D. Pan, E.A. Montgomery, and R.A. Anders Expression of Yes-associated protein in common solid tumors Hum. Pathol. 39 2008 1582 1589
33. P.J. Stork, and J.M. Schmitt Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation Trends Cell Biol. 12 2002 258 266 (Pubitemid 34634174)
34. E.J. van Corven, A. Groenink, K. Jalink, T. Eichholtz, and W.H. Moolenaar Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins Cell 59 1989 45 54 (Pubitemid 19248557)
35. C.D. Van Raamsdonk, K.G. Griewank, M.B. Crosby, M.C. Garrido, S. Vemula, T. Wiesner, A.C. Obenauf, W. Wackernagel, G. Green, and N. Bouvier Mutations in GNA11 in uveal melanoma N. Engl. J. Med. 363 2010 2191 2199
36. P. Wellendorph, K.B. Hansen, A. Balsgaard, J.R. Greenwood, J. Egebjerg, and H. Bräuner-Osborne Deorphanization of GPRC6A: a promiscuous L-alpha-amino acid receptor with preference for basic amino acids Mol. Pharmacol. 67 2005 589 597 (Pubitemid 40365305)
37. N. Wettschureck, and S. Offermanns Mammalian G proteins and their cell type specific functions Physiol. Rev. 85 2005 1159 1204 (Pubitemid 41362268)
38. M.Z. Xu, T.J. Yao, N.P. Lee, I.O. Ng, Y.T. Chan, L. Zender, S.W. Lowe, R.T. Poon, and J.M. Luk Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma Cancer 115 2009 4576 4585
39. Y. Xu, I. Stamenkovic, and Q. Yu CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma Cancer Res. 70 2010 2455 2464
40. L. Zender, M.S. Spector, W. Xue, P. Flemming, C. Cordon-Cardo, J. Silke, S.T. Fan, J.M. Luk, M. Wigler, and G.J. Hannon Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach Cell 125 2006 1253 1267 (Pubitemid 43929093)
41. N. Zhang, H. Bai, K.K. David, J. Dong, Y. Zheng, J. Cai, M. Giovannini, P. Liu, R.A. Anders, and D. Pan The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals Dev. Cell 19 2010 27 38
42. B. Zhao, X. Wei, W. Li, R.S. Udan, Q. Yang, J. Kim, J. Xie, T. Ikenoue, J. Yu, and L. Li Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control Genes Dev. 21 2007 2747 2761 (Pubitemid 350070721)
43. B. Zhao, X. Ye, J. Yu, L. Li, W. Li, S. Li, J. Yu, J.D. Lin, C.Y. Wang, and A.M. Chinnaiyan TEAD mediates YAP-dependent gene induction and growth control Genes Dev. 22 2008 1962 1971 (Pubitemid 352008643)
44. B. Zhao, L. Li, Q. Lei, and K.L. Guan The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version Genes Dev. 24 2010 862 874
45. B. Zhao, L. Li, K. Tumaneng, C.Y. Wang, and K.L. Guan A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP) Genes Dev. 24 2010 72 85
46. B. Zhao, L. Li, L. Wang, C.Y. Wang, J. Yu, and K.L. Guan Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis Genes Dev. 26 2012 54 68
47. D. Zhou, C. Conrad, F. Xia, J.S. Park, B. Payer, Y. Yin, G.Y. Lauwers, W. Thasler, J.T. Lee, J. Avruch, and N. Bardeesy Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene Cancer Cell 16 2009 425 438